Patient | Screening indication | US abdomen result | FibroScan result kPa | FibroScan fibrosis grade | FibroSure result | FibroSure fibrosis grade | CT abdomen result | MRI abdomen result | Liver biopsy result |
1 | ABN US | Steatosis | — | — | — | — | Steatosis | — | — |
2 | ABN US | Steatosis | — | — | — | — | — | Steatosis | — |
3 | ABN US | Steatosis | — | — | — | — | Mild steatosis | — | — |
4 | ABN US | Steatosis | 5.1 | F0–F1 | 0.52 | F2 | — | — | Steatosis |
5 | ABN US | Steatosis | 4.2 | F0–F1 | 0.54 | F2 | — | — | — |
6 | Short telomere | Normal | 4.9 | F0–F1 | — | — | — | — | — |
7 | ABN US | Steatosis | 6.9 | F0–F1 | 0.33 | F1–F2 | — | — | — |
8 | ABN US | Steatosis | 3.9 | F0–F1 | NR | — | — | — | — |
9 | ABN US | Steatosis | — | — | 0.54 | F2 | — | — | — |
10 | ABN US | Steatosis | — | — | — | — | — | — | — |
11 | ABN US | Steatosis | 5.4 | F0–F1 | — | — | Normal | — | — |
12 | ABN US | Steatosis | — | — | 0.14 | F0 | — | — | — |
13 | ABN US | Steatosis | — | — | 0.32 | F1–F2 | Normal | — | — |
14 | ABN US | Steatosis | 4.9 | F0–F1 | — | — | — | — | — |
15 | Short telomere/ethanol abuse | Normal | 5.5 | F0–F1 | — | — | Normal | — | — |
16 | ABN US | Steatosis | 4.4 | F0–F1 | — | — | — | — | — |
17 | ABN US | Steatosis | NR | — | 0.12 | F0 | — | — | — |
18 | ABN US | Steatosis | 7.1 | F1 | 0.18 | F0 | Normal | — | — |
19 | ABN LFTs | Normal | 44.3 | F4 | 0.69 | F3 | — | Normal | Mild fibrosis |
20 | ABN LFTs | Normal | 5.1 | F0–F1 | — | — | — | — | — |
21 | ABN US | Steatosis | 6.2 | F0–F1 | — | — | — | — | — |
22 | ABN US | Steatosis | 7.7 | F2 | — | — | — | — | — |
23 | ABN US | Steatosis | 6.1 | F0–F1 | — | — | Normal | — | — |
24 | HCV | Normal | NR | — | 0.86 | F4 | Normal | — | |
25 | ABN US | Steatosis | 4.8 | F0–F1 | 0.19 | F0 | Normal | — | — |
26 | ABN US | Steatosis | 7 | F0–F1 | 0.39 | F1–F2 | — | — | — |
27 | ABN US | Steatosis | 5.4 | F0–F1 | — | — | — | — | — |
28 | ABN US | Steatosis | 4.9 | F0–F1 | — | — | — | — | — |
29 | ABN US | Steatosis | 2.3 | F0–F1 | — | — | — | — | — |
30 | ABN US | Steatosis | — | — | — | — | — | Steatosis | — |
31 | ABN US | Steatosis | 6.8 | F0–F1 | — | — | — | — | — |
32 | ABN US | Steatosis | 4.2 | F0–F1 | — | — | — | — | — |
33 | ABN US | Steatosis | 4.5 | F0–F1 | — | — | — | — | — |
34 | ABN US | Steatosis | — | — | — | — | — | Steatosis | — |
35 | ABN US | Steatosis | 3.5 | F0-F1 | — | — | — | — | — |
36 | ABN US | Steatosis | NR | — | — | — | — | — | Mild steatosis |
37 | ABN US | Steatosis | 10.1 | F3 | 0.1 | F0 | Normal | — | Mild fibrosis |
38 | ABN US | Steatosis | 6.8 | F0–F1 | 0.47 | F1–F2 | Normal | — | — |
39 | ABN US | Steatosis | 3.6 | F0–F1 | 0.17 | F0 | Normal | — | — |
40 | ABN US | Steatosis | 4.4 | F0–F1 | 0.46 | F1–F2 | Normal | — | — |
CT: computed tomography; MRI: magnetic resonance imaging; ABN US: abnormal ultrasound; ABN LFTs: abnormal liver function tests; HCV: hepatitis C virus.